Gibson Dunn, partnered with PwC on Japanese tax and Nagashima Ohno & Tsunematsu on Japanese legal matters, represented funds advised by Neuberger Berman. Evercore Asia Pte....
J-STAR’s JPY 17.9 Billion Closing of J-STAR Continuation Series Funds
Merck’s Acquisition of Caraway Therapeutics, Inc.
Gibson, Dunn & Crutcher LLP advised Merck on its acquisition of Caraway Therapeutics, Inc. Merck (NYSE: MRK), known as MSD outside of the United States and...
USD Partners LP and and USD Terminals Canada ULC’s Amendment of Revolving Credit Agreement
Gibson, Dunn & Crutcher LLP served as legal advisor to the Partnership and Lazard acted as financial advisor to the Partnership. On November 21, 2023, USD...
The Duckhorn Portfolio’s Acquisition of Sonoma-Cutrer Vineyards
Brown?Forman’s financial advisor was Greenhill & Co., LLC and its legal advisors were Gibson, Dunn & Crutcher LLP and Coblentz Patch Duffy & Bass LLP. Brown-Forman...
Hess Midstream LP’s $100 Million Sponsor Unit Repurchase
Gibson, Dunn & Crutcher LLP is assisting the Conflicts Committee of the Board of Directors of Hess Midstream LP on the repurchase. Hess Midstream LP (NYSE:...
SMX’s Acquisition of Outside Analytics
KippsDeSanto & Co. served as exclusive financial advisors and Sparks Willson, P.C. as legal counsel to Outside Analytics. Gibson, Dunn & Crutcher, LLP served as legal...
WPG’s Transformational Portfolio Refinance
Gibson, Dunn and Crutcher LLP provided legal counsel to WPG and Strategic Value Partners. Cleary Gottlieb Steen & Hamilton LLP served as legal counsel to the...
Royalty Pharma’s Partnership with Teva Pharmaceuticals International GmbH
Gibson, Dunn & Crutcher LLP advised Royalty Pharma in connection with its development funding. Royalty Pharma plc (Nasdaq: RPRX) and Teva Pharmaceuticals International GmbH, a subsidiary...
Wise Equity SGR’s Acquisition of Majority Stake in Wanho
In the operation, Wise Equity SGR and Fi.Mo.Tec are supported by Benesch, Simmons & Simmons and PwC; Wanho is assisted by Gibson Dunn; financial institutions are...
Sumeru Equity Partners’ C$257 Million Acquisition of Q4 Inc.
Raymond James acted as exclusive financial advisor to the Special Committee. Stifel Canada acted as independent valuator to the Special Committee. Osler, Hoskin & Harcourt LLP...
Calumet Specialty Products Partners, L.P.’s Corporate Transition
Gibson, Dunn & Crutcher LLP is advising Calumet Specialty Products Partners, L.P. on the transaction. Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) announced the execution of an...
Welltower’s $1.5 Billion Public Offering
Gibson, Dunn & Crutcher LLP represented Welltower Inc. in the offering. Welltower Inc. (NYSE: WELL) priced the public offering for the 17,500,000 shares of its common stock...